Related Experiment Video
Updated: Sep 27, 2026

Assessing Functional Performance in the Mdx Mouse Model
Published on: March 27, 2014
The clinical meaning of functional outcome scores in children with juvenile arthritis
H Dempster1, M Porepa, N Young
1University of Toronto, Ontario, Canada.
Insights
A minimal clinically important improvement for the Childhood Health Assessment Questionnaire (CHAQ) in pediatric arthritis is a score reduction of 0.13. This finding aids clinicians and researchers in setting treatment goals for children with arthritis.
Area of Science:
- Pediatric Rheumatology
- Clinical Outcomes Measurement
Background:
- The Childhood Health Assessment Questionnaire (CHAQ) is a standard functional measure for childhood arthritis.
- CHAQ scores range from 0 (no disability) to 3 (severe disability).
Purpose of the Study:
- To establish CHAQ score cutoffs for disability levels (none, mild, moderate, severe).
- To determine the minimal clinically important change (MCIC) in CHAQ scores.
- To compare parent-reported and self-reported MCIC in older children.
Main Methods:
- 136 parents of children with arthritis completed the CHAQ assessing current status, slight improvement, and slight worsening.
- Parents also used a subjective disability scale.
- Children aged 10+ completed the CHAQ independently.
Main Results:
- Most pediatric patients had no, mild, or moderate disability.
- Median CHAQ scores for no, mild, mild-to-moderate, and moderate disability were 0, 0.13, 0.63, and 1.75, respectively.
- MCIC for improvement was 0.13; for deterioration, it was 0.75. Self-assessments showed no significant differences.
Conclusions:
- Clinicians and researchers should target a minimum CHAQ score improvement of 0.13 for pediatric arthritis patients.
- The identified cutoffs and MCIC provide valuable benchmarks for functional status assessment.
Objective:
The Childhood Health Assessment Questionnaire (CHAQ) is the most widely used measure of function in childhood arthritis and yields a score of 0 (no disability) to 3 (very severe disability). This study ascertained the cutoff levels for CHAQ scores that represent no, mild, moderate, and severe disability, to determine the minimal clinically important change in scores and to determine whether the minimal important change in scores is similar for parent-reported assessments and the self-assessments provided by their older children.
Methods:
One hundred thirty-six parents of children with arthritis were interviewed. They were asked to complete the CHAQ by assessing their child's functional status under 3 categories: current health, a hypothetical small improvement, and a hypothetical small worsening. They also completed a categorical scale of subjective disability. Those children who were > or = 10 years old also completed the CHAQ interview separately.
Results:
The pediatric patients had mostly no, mild, or moderate disability. For those children rated as having no disability, the median CHAQ score was 0. The median CHAQ scores corresponding to mild, mild-to-moderate, and moderate disability were 0.13, 0.63, and 1.75, respectively. The minimal clinically important improvement was a reduction in score of 0.13. The minimal clinically important deterioration was a median change in score of 0.75. This discrepancy may be due to the ceiling effect seen with the CHAQ. There were no significant differences when the children assessed themselves.
Conclusion:
Clinicians, as well as researchers setting protocols, should aim for a mimimum improvement of 0.13 in the CHAQ score when treating pediatric patients with arthritis.
More Related Videos
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
07:20Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
Published on: August 9, 2024
Related Concept Videos
Clinical Trials: Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Chronic Kidney Disease II: Clinical Manifestations
Asthma III: Clinical Manifestations
Inflammatory Bowel Disease IV: Clinical Manifestations